Affordable Robo. (AFFORDABLE)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹181.89 |
| Market Cap | ₹215.56 Cr |
| P/E Ratio | 29.34 |
| ROCE | -2.63% |
| ROE | 10.62% |
| Dividend Yield | 0% |
| Profit Growth | 178.92% |
| Debt/Equity | 0.67 |
| Sales Growth | -40.9% |
| Promoter Holding | 43.24% |
| 52-Week Range | ₹119.71 — ₹297 |
| Sector | Industrial Manufacturing |
| Book Value | ₹98.02 |
Strengths
- Profit grew 178.92% and the latest quarter is profitable (₹1 Cr net profit), suggesting a possible bottom
- Promoter holding of 43.24% aligns owner interests with minority shareholders
- Book value of ₹87.83 provides a tangible asset reference point
- Piotroski F-score of 5/9 indicates moderate overall financial health, not a distressed balance sheet
Concerns
- Revenue declined 42.10% year on year; latest quarter sales of only ₹20 Cr makes current earnings power very thin
- ROCE is negative at -2.63%, meaning operations are not covering the cost of capital
- P/E of 44.76, and close to 50x on annualised latest quarter profits, leaves no margin of safety
- Zero dividend yield and debt/equity of 0.69 add financial strain while operating returns are weak
AI Analysis
At first glance, Affordable Robo looks tempting: a 178.92% jump in profit and a PEG ratio of 0.25. But a value investor must look behind the headline. Sales have collapsed 42.10%, and the latest quarter shows only ₹20 crore of revenue and ₹1 crore of net profit. At a market cap of ₹201 crore, that annualises to roughly ₹4 crore of earnings, putting the real P/E closer to 50 times. Meanwhile, ROCE is negative at -2.63%, meaning the business is not yet earning more than its cost of capital. The 10.62% ROE is thin, and debt/equity of 0.69, while not extreme, is uncomfortable when operating returns are negative. There is no dividend to compensate patient shareholders. Book value of ₹87.83 is the one tangible anchor, but at ₹184.80 I am paying more than two times book. Promoter holding at 43.24% indicates skin in the game, and a Piotroski score of 5/9 suggests only moderate financial health. The profit growth is likely a low-base effect, not evidence of durable momentum. Benjamin Graham would say price is what you pay, value is what you get. Here, I cannot yet see value. This may be a turnaround, but turnarounds require operational proof: stabilised revenue, positive ROCE, and cash generation. Until I see consistent quarterly improvement, the high P/E and negative ROCE keep me on the sidelines. I would rather miss a speculative rebound than risk permanent capital in a business whose fundamentals have not turned. Patience is a virtue in investing; I will wait for better evidence.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer